Viewing Study NCT00396266


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2025-12-29 @ 2:03 AM
Study NCT ID: NCT00396266
Status: COMPLETED
Last Update Posted: 2014-03-07
First Post: 2006-11-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF
Sponsor: Genzyme, a Sanofi Company
Organization: